Jay Raval

Associate Professor and Vice Chair for Clinical Affairs

University of New Mexico Health Sciences Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jay Raval is an Associate Professor and Vice Chair for Clinical Affairs at the Health Sciences Center, University of New Mexico, USA. His research areas include therapeutic plasma exchange, extracorporeal membrane oxygenation, and the management of traumatic injuries and coagulopathies. Recent publications highlight his work on the feasibility of plasma exchange in severely injured patients, mathematical modeling of exchange kinetics, and strategies for personal protective equipment conservation in clinical settings.

Articles (12)

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Jasmeet Paul

Professor

University of New Mexico

UNITED STATES

View details

Monica B. Pagano

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jay Raval

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Therapeutic plasma exchange is feasible and tolerable in severely injured patients with trauma-induced coagulopathy

Utilizing triple tandem extracorporeal membrane oxygenation, therapeutic plasma exchange, and continuous renal replacement therapy in a neonate with elevated plasma‐free hemoglobin

Vitamin K antagonist reversal strategies: Systematic review and network meta‐analysis from the AABB

Anti‐D alloimmunization in Rh(D) negative adults with severe traumatic injury

Mathematical modeling of the impact of recirculation on exchange kinetics in tandem extracorporeal membrane oxygenation and therapeutic plasma exchange

Adverse event reporting for cellular therapy products: Current status and future directions

A strategy to conserve personal protective equipment while performing therapeutic plasma exchange in a patient with COVID‐19

Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients

Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass?

Traumatic injury results in prolonged circulation of ultralarge von Willebrand factor and a reduction in ADAMTS13 activity

Viscoelastic testing in COVID‐19: a possible screening tool for severe disease?

Total plasma volume determinations for patients with potentially challenging conditions requiring therapeutic plasma exchange: Dealer's choice

Collaborators (2)

Jasmeet Paul

Monica B. Pagano

Make your next move.